Swiss pharma giant Novartis on Friday revealed plans to build its fourth US radioligand therapy (RLT) manufacturing facility ...

US pharma Madrigal Pharmaceuticals, which is focused on delivering novel therapeutics for metabolic dysfunction-associated ...

Shares of US cancer drug Revolution Medicines, with a market capitalization of more than $20 billion, rose nearly 29% following reports of a buyout from US pharma giant Merck & Co.

Noetik, an AI-native biotech company developing self-supervised machine learning and high-throughput spatial data to develop ...

New Jersey, USA-based Aquestive Therapeutics saw its shares plummet nearly 48% to $3.25 (Nasdaq: AQST) pre-market today, ...

This morning, USA-based biotech AirNexis Therapeutics announced its launch with the close of its oversubscribed $200 million ...

Chinese pharma Hansoh Pharma (HKEX: 3692) has secured approval from China’s National Medical Products Administration for an ...

China-based BioRay Biopharmaceutical has submitted an application to list on the Hong Kong Stock Exchange, setting out plans ...

US biotech ecosystem company Alloy Therapeutics has appointed Christian Cobaugh as chief executive of its Genetic Medicines ...

US drugmaker Vanda Pharmaceuticals yesterday announced that it has received a decision letter from the US Food and Drug ...

Eli Lily has announced positive topline results from the novel TOGETHER-PsA open-label Phase IIIb trial evaluating ...

Cambridge, USA-based Parabilis Medicines (formerly FogPharma), a clinical-stage biopharmaceutical company committed to ...